Press & Media

John Thievon; Strategic and Visionary Driver Behind Rapid Turnarounds, Start Up Success, and Revolutionary Product Launches, Leading to Impressive Revenue Growth and Lasting Stakeholder Value

Read
Mylan Names John Thievon President of Dey Pharma
Read
Thievon appointed president of Dey Pharma
Read
John Thievon named Dey Pharma president  
Read

MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)

Read

John Thievon saves the Dey for Mylan

Read

John Thievon & David Becker – Middlebrook Pharmaceuticals, Inc. (mbrk)

Read

Retooled Middlebrook Gears Up for Big Patch

Read

John Thievon: Leading Health Care Organizations Toward Scalable, Long-Term Success

Read
Thievon Consulting